TY - JOUR
T1 - Drug treatment programs' HCV service delivery to their HCV positive clients
AU - Astone-Twerell, Janetta M.
AU - Strauss, Shiela M.
AU - Hagan, Holly
AU - Des Jarlais, Don C.
N1 - Funding Information:
Correspondence: Janetta Astone-Twerell Ph.D., National Development and Research Institutes, Inc., 71 West 23rd Street, 8th Floor, New York, New York 10010, USA. Tel.: 212-845-4407. Fax: 917-438-0894. E-mail: [email protected] *Funding for this study was provided by the National Institute on Drug Abuse (grant no. 1-R01 DA13409). Points of view do not represent the official positions of the Federal government, NIDA, or NDRI.
PY - 2006/6/1
Y1 - 2006/6/1
N2 - Hepatitis C virus (HCV) infection is the most common blood-borne infectious disease among drug users in the US. Drug treatment programs are ideally situated to assist their clients to obtain HCV medical and support services. Using data collected from 233 drug free and methadone maintenance treatment programs (MMTPs) throughout the US, this article examines the range of HCV services that treatment programs provide to their HCV positive clients. Findings indicate that MMTPs offer more comprehensive HCV services to more of their HCV positive clients than drug free programs, although drug free programs provide more individualized services. While 84% of the programs provided some HCV services, there are still serious gaps in the provision of these services (e.g., dealing with medical providers to obtain HCV medication and facilitating access to liver transplant lists). Drug treatment programs need increased funding and staff training to be able to provide comprehensive HCV services to their HCV positive clients.
AB - Hepatitis C virus (HCV) infection is the most common blood-borne infectious disease among drug users in the US. Drug treatment programs are ideally situated to assist their clients to obtain HCV medical and support services. Using data collected from 233 drug free and methadone maintenance treatment programs (MMTPs) throughout the US, this article examines the range of HCV services that treatment programs provide to their HCV positive clients. Findings indicate that MMTPs offer more comprehensive HCV services to more of their HCV positive clients than drug free programs, although drug free programs provide more individualized services. While 84% of the programs provided some HCV services, there are still serious gaps in the provision of these services (e.g., dealing with medical providers to obtain HCV medication and facilitating access to liver transplant lists). Drug treatment programs need increased funding and staff training to be able to provide comprehensive HCV services to their HCV positive clients.
KW - Drug treatment programs
KW - HCV service delivery
KW - Hepatitis C
KW - Injection drug users
KW - Methadone maintenance programs
KW - Telephone survey
UR - http://www.scopus.com/inward/record.url?scp=33746858910&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33746858910&partnerID=8YFLogxK
U2 - 10.1080/16066350500262742
DO - 10.1080/16066350500262742
M3 - Article
AN - SCOPUS:33746858910
SN - 1606-6359
VL - 14
SP - 289
EP - 302
JO - Addiction Research and Theory
JF - Addiction Research and Theory
IS - 3
ER -